CWBR

CohBar (CWBR)

About CohBar (CWBR)

CohBar, Inc. is a clinical stage biotechnology company, which engages in the research and development of mitochondria-based therapeutics targeting chronic and age-related diseases. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.

Details

Daily high
$0.52
Daily low
$0.49
Price at open
$0.52
52 Week High
$2.72
52 Week Low
$0.00
Market cap
1.4M
Dividend yield
0.00%
Volume
44
Avg. volume
2,188
P/E ratio
--

CohBar News

Details

Daily high
$0.52
Daily low
$0.49
Price at open
$0.52
52 Week High
$2.72
52 Week Low
$0.00
Market cap
1.4M
Dividend yield
0.00%
Volume
44
Avg. volume
2,188
P/E ratio
--